INTRODUCTION
The pathogenesis of nasopharyngeal cancer (NPC) is unclear. Currently, the therapeutic effect of NPC relies on the early diagnosis and early treatment. 1 However, because the anatomical feature of the nasopharyngx, many NPC cases are diagnosed at the advanced stages with metastasis has already occurred. 2 The therapeutic effect on those advanced NPC cases is still poor currently. 3 Thus, it is necessary to identify novel therapeutic targets to enhance the therapeutic effect for NPC.
It is proposed that immune regulatory cells, such as regulatory T cells and regulatory B cells, play an important role in facilitating cancer cells to escape from the immune surveillance. 4 The immune regulatory cells release immune regulatory molecules, including transforming growth factor-b, 5 interleukin (IL)-10, 6 etc. to inhibit the functions of antitumor cells, such as CD8 1 cytotoxic T cells. 7 However, the generation of the regulatory immune cells remains to be further understood.
MicroRNAs (miR) are small non-coding RNA molecules (containing about 22 nucleotides) found in plants, animals, and some viruses, which functions in RNA silencing and post-transcriptional regulation of gene expression. 8 A number of miRs have been recognized to be involved in the cancer progression 9 and to be considered being potential biomarkers and therapeutic targets for gastric cancer. 10 Several miRs have been detected in NPC, such as miR-21, which may play a role in NPC metastasis. 11 MiR-21 is also significantly upregulated in many cancers, which may play an important role in cancer cell survival, apoptosis and invasion. 12 Recent reports indicate that miR-21 modulates the expression of a large number of cancerrelated genes including phosphatase and tensin homolog, TPM1 and programmed cell death protein 4, etc. 12 It is reported that miR-21 regulates lymphocyte function. 13 Based on the above information, we hypothesize that miR-21 facilitate the development of regulatory immune cells. In this study, we observed that NPC cells produced miR-21, which induced the development of IL-10-producing B cells; the latter showed the capacity to suppress cytotoxic CD8 1 T-cell activities.
MATERIALS AND METHODS

Reagents
The antibody and shRNA kit of IL-10 (E-10) were purchased from Santa Cruz Biotech (Santa Cruz, CA, USA). The fluorochrome-labeled antibodies (for flow cytometry) were purchased from BD Biosciences (Shanghai, China). The Poly I:C, gemcitabine hydrochloride were purchased from Sigma-Aldrich (Shanghai, China). The ELISA kits were purchased from R&D Systems (Shanghai, China). The antisense of miR-21 was synthesized by GenScript (Guangzhou, China). The reagents for real-time quantitative RT-PCR (RT-qPCR) and western blotting were purchased from Invitrogen (Shanghai, China).
Ethic statement
The using human tissue in the present study was approved by the Human Research Ethic Committee at Shenzhen University in accordance of the guidelines. An informed, written consent was obtained from each subject.
NPC and adenoid gland tissue collection and single cell isolation
The diagnosis and the surgical operation of NPC or chronic adenoiditis were performed by the otolaryngologists following the routine procedures of our department. The surgically removed NPC or adenoid gland tissue was collected from the operation rooms, cut into small pieces (23232 mm) and incubated with 0.5% Collagenase IV for 2 h at 37 uC. The cells were filtered through a cell strainer (70 mm). The single cells were collected by centrifugation. The mixing immune cells, including CD3 1 T cells, CD19 1 B cells, CD11c 1 dendritic cells and CD14 1 monocytes, were removed by the magnetic cell sorting (MACS; see below). The viability of the isolated cells was 98.8% as assessed by the trypan blue exclusion assay.
Preparation of peripheral blood mononuclear cells (PBMCs)
Twenty millilitres of peripheral blood were withdrawn from the elbow vein of each NPC patient or a healthy volunteer. PBMCs were isolated by the gradient density centrifugation. 14 
Immune cell isolation
Following our established procedures, 15 the immune cell isolation was performed by MACS with commercial reagent kits following the manufacturer's instructions. The isolated immune cell purity was greater than 98% as assessed by flow cytometry.
Flow cytometry
Following our established procedures, 15 cells were fixed by 2% paraformaldehyde for 2 h. In the case of intracellular staining, the fixative contained 0.1% Tryton X-100 to enhance the cell membrane permeability. After washing with phosphate-buffered saline, the cells were blocked with 1% bovine serum albumin for 30 min and stained with fluorochrome-labeled antibodies at concentrations of 0.1-0.5 mg/ml for 1 h on ice. The cells were washed with phosphate-buffered saline again and analyzed with a flow cytometer (FACSCanto II; BD Biosciences, Shanghai, China). The data were analyzed with the FlowJo software.
C666-1 NPC cell culture
Following the routine cell culture procedures of our laboratory, 16 the C666-1 cells (a human NPC cell line; purchased from ATCC) were cultured in DMEM supplemented with 10% fetal bovine serum, 100 U/ml penicillin, 0.1 mg/ml streptomycin and 2 mM L-glutamine. Before using for further experiments, the viability of the cells was assessed by trypan blue exclusion assay; it was greater than 99%.
RT-qPCR
Following published procedures, 17 the concentration of miR-21 in NPC cells was determined with RT-qPCR. The mature miRNA was reverse transcribed using miRNA-specific primers for quantification of miR-21. RT-qPCR was performed on a qPCR device (miniOpticon real-time RT-PCR System; BioRad, Shanghai, China) using SYBR Green Master Mix. Small nuclear RNA U6 (snRNA U6) was used as an internal control 17 and was used to normalise miR-21 results; the results were calculated using the 2 2DDCt method. 18 The data were presented as a percentage of the U6.
Western blotting
Following our established procedures, 15 the total proteins were extracted from the cells, fractioned by SDS-PAGE and transferred onto a PVDF membrane. After blocking with 5% skim milk for 30 min at room temperature, the membrane was incubated with the primary antibodies at concentrations of 0.1-0.3 mg/ml at 4 uC overnight. The membrane was washed with Tris-buffered saline Tween 20 for three times (5 min each time) and followed by incubating with the secondary antibodies (conjugated with horseradish peroxidase). The membrane was washed with Tris-buffered saline Tween 20 again. The immune complexes on the membrane were developed by ECL. The immune blots were photographed with an imaging device (Kodak Image Station 4000 mm Pro, KODAK; Shanghai, China). The density of the immune blots was determined with software Photoshop CS5, Adobe Systems Inc, San Jose, CA and presented as a percentage of the internal control b-actin.
Methylation-specific PCR Following our established procedures, 19 the DNA was extracted from the cells with a reagent kit. The DNA was treated with 2 M NaOH at 37 uC for 10 min, followed by incubating with 3 M sodium bisulphite (pH 5.0) and incubated at 50 uC overnight (covered by mineral oil). The samples were treated with 3 M NaOH for 5 min and then concentrated by ammonium precipitation and 100% ethanol, washed with 70% ethanol and resuspended in 20 ml distilled water. Methylation-specific PCR was performed with the samples to determe the amount of demethylated DNA of the IL-10 promoter. Left U primer, tttggaatatattttgtgattttgt; Right U primer, ccctcaactataaattctcattcaca. The results were normalized to a percentage of the input. Ten CpG sites between 653 and 947 of the IL-10 promoter were analyzed.
Generation of IL-10
1 B cells Following our established procedures, 19 CD19 1 IL-7R 1 naive B cells were isolated from PBMC by MACS (the purity was greater than 98%) and cultured in the presence of anti-CD40 (20 ng/ml) and miR-21 (10 ng/ml) for 6 days. As assessed by flow cytometry, the frequency of IL-10 1 B cells was more than 90%.
CD8
1 T-cell proliferation assay Following our estabolished procedures, 7 CD8 1 CD25 2 T cells were isolated from the PBMCs by MACS (the purity was more than 98%), stained with CFSE and cultured for 3 days in the presence of IL-2 (20 ng/ml), PMA (20 ng/ml), an anti-CD3 antibody (coated on the well of 96-well plates) and an anti-CD28 antibody (5 mg/ml). The cells were analyzed by flow cytometry (the CFSE-dilution assay).
Enzyme-linked immunosobent assay (ELISA)
The levels of perforin and granzyme B in the culture supernatant were determined by ELISA with commercial reagent kits following the manufacturer's instructions and our established procedures. 7 
Nuclear factor I-A (NFI-A) gene silence
The NFI-A gene in B cells was silenced by the RNA interference using a commercial reagent kit following the manufacturer's instructions and our established procedures. 15 The effect of the gene knockdown was assessed by western blotting.
Statistics
The data are presented as mean6s.d. Differences between groups were determined by ANOVA. The P,0.05 was set as a significant criterion.
RESULTS
IL-10-producing B cells are increased in NPC
IL-10-producing B cells have the immune suppressor functions that may be associated with cancer progression. 20 We infer that the intratumor IL-10 1 B cells may play a role in the pathogenesis of NPC. To test the hypothesis, we prepared single cells from surgically removed NPC tissue; the cells were analyzed by flow cytometry. The results showed that about 6.32% B cells were detected in the NPC-derived cells (Figure 1a and g ), of which more than 90% B cells expressed IL-10 ( Figure 1b and h ). Using as a control, we collected surgically removed adenoid gland tissue to be processed in the same procedures of NPC. The results showed much more B cells were detected in the adenoid gland (Figure 1c and g ), but the IL-10 1 B cells were much less (6.16%) (Figure 1d and h) than that in NPC. We also collected PBMC from the same NPC patients, in which the frequency of IL-10 1 B cells was about 7.94% (Figure 1e-h ), also much less than that in NPC. The results implicate that the microenvironment in NPC may induce the expression of IL-10 in the intra-NPC B cells.
Activation of TLR3 upregulates expression of miR-21 in NPC cells
It is reported that the levels of miR-21 are elevated in NPC tissue 21 and miR-21 increases the IL-10 expression. 22 NPC cells express TLR3, 23 Epstein-Barr virus ligates TLR3 to influence NPC cell activities (Verillaud et al., 2012) . Based on the information, we hypothesize that activation of TLR3 enhances the expression of miR-21 in NPC cells; the miR-21 then modulates the expression of IL-10 in the intra-NPC B cells. To test the hypothesis, C666-1 cells (a NPC cell line) were cultured in the presence or absence of Poly I:C for 48 h. As shown by RTqPCR data, the expression of miR-21 was detectable in C666-1 cells; exposure to Poly I:C in the culture markedly increased the levels of miR-21 in a Poly I:C dose-dependent manner. The expression of miR-21 was also detected in the surgically removed NPC tissue that was significantly higher than that in the adenoid gland tissue (Figure 2) . The results indicate that NPC cells express miR-21, which can be upregulated by TLR3 activation.
NPC-derived miR-21 upregulates expression of IL-10 in B cells
We then cultured C666-1 cells with naive B cells in the presence of Poly I:C. The cells were then analyzed by flow cytometry. The results showed that the expression of IL-10 was hardly detectable in the B cells cultured in medium alone (Figure 3a and l) . Cultured with NPC cells increased the frequency of IL-10 1 B cells (Figure 3b and l) , which was further increased after the addition of Poly I:C to the culture (Figure 3c and l) . To test the role of the NPC-derived miR-21 in the increase in the IL-10 expression in the B cells, an antisense of miR-21 was added to the culture in a separate experiment with the same procedures above; indeed, the expression of IL-10 was abolished (Figure 3d and l). To elucidate if the 'cell-cell-contact' was required in the process of NPC-induced IL-10 expression in B cells, in a separate experiment, cells were cultured in a transwell system with NPC cells in the inserts and B cells in the basal chambers in addition to the same procedures above. The expression of IL-10 in the B cells was still induced (Figure 3e and l) . To strengthen the results, we added miR-21 to the culture of B cells; it also increased the expression of IL-10 in the B cells (Figure 3f and l) . Since the transcription factor NFI-A is involved in the miR-21-induced IL-10 expression, we knocked down the gene of NFI-A in B cells (Figure 3k ). After exposure to the PolyIC-activated NPC, the NFI-A-deficient B cells did not increase the expression of IL-10 (Figure 3h-i) . The results indicate that the NPCderived miR-21 enhances the expression of IL-10 in B cells.
To take further insight into the underlying mechanism by which miR-21 upregulates the IL-10 expression in B cells, in the same procedures above, we added gemcitabine, an inhibitor of demethylation, to the culture; it abolished the increase in the NPC-induced IL-10 expression in the B cells (Figure 3g and l) . 
NFI-A is involved in the miR-21-induced expression of IL-10 in B cells
The transcription factor NFI-A is a downstream target of miR-21 in the regulation of IL-10 expression in dendritic cell. 24 We inferred that the NFI-A might be also involved in the induction of IL-10 in B cells. To this end, we added miR-21 to the B-cell culture and analyzed the levels of NFI-A in the B-cell extracts. The results showed that NFI-A was detectable in naïve B cells. Exposure to miR-21 significantly increased the levels of NFI-A. Similar results were obtained when B cells were cultured with NPC cells (Figure 5 ). To strengthen the data, we silenced the NFI-A gene in B cells (Figure 3k) ; then the NFI-A-null B cells were exposed to miR-21 in the culture. Indeed, the induction of IL-10 in the B cells was abolished (Figure 3h and i) . The results suggest that NFI-A was in the signal transnduction pathway by which miR-21 induces IL-10 expression in B cells.
Assessment of the immune suppressor functions of NPCinduced IL-10
1 B cells Published data indicate that IL-10 1 B cells have immune suppressor functions. 25 We then tested the capacity of the NPCinduced IL-10 1 B cells in the suppression of the cytotoxic 26 Epstein-Barr virus-encoded latent membrane protein 1 is associated with tumor relapse and poor prognosis of nasopharyngeal carcinoma. 27 It is proposed that the genetic polymorphisms of TLR3 are associated with nasopharyngeal carcinoma risk. 28 Our data are in line with these previous studies by showing that the exposure to TLR3 ligands, the Poly I:C, activates NPC cells; such an activation induces the expression of miR-21 by NPC cells.
Published data have shown that the production of miR-21 is associated with NPC cell activities. Yang et al. 29 indicate that NPC upregulates miR-21 to promote the resistance of nasopharyngeal carcinoma cells to cisplatin-induced apoptosis. 29 Li Apart from NPC cells and inducing the IL-10 expression in B cells, other tissue and cells also produce miR-21 with various activities. Hu et al. 32 indicate that administration with miR-21 decreases in programmed cell death 4 mRNA and caspase-3, caspase-8 protein expressions, and thus, inhibits apoptosis and reduces tissue injury. 32 The reduction of apoptosis is an important pathological feature of cancer. Whether the NPCderived miR-21 plays any roles in interfering with cell apoptosis in NPC is worth being further investigated.
Cancer tolerance is a critical mechanism by which cancer cells escape from the immune surveillance. Thus, to elucidate the underlying mechanism by which the cancer tolerance is developed is of significance. The present data demonstrate that the NPC-derived miR-21 is one of the factors to facilitate the development of cancer tolerance. The evidence to support this notion includes that NPC-derived miR-21 can activate NFI-A and induce IL- 
